HLA-DRB1 and congenital rubella syndrome: Our results extends previous observations on risk factors for the development of life‐threatening CRS since we have identified that disease burden (pretransplant active disease), HLA‐DRB1 mismatching, and graft type (PBSC vs BM) were significantly associated with a higher incidence of grade ≥3 CRS.